Russian Pharmalicensing Group - News

+7 495 640 5275
info@regulatoryaffairs.ru

PHARMALICENSING NEWS

Keeping clients informed is one of our major priorities. Be the first to get updates on regulatory issues and news.

Russian Pharmaceutical Market: Results of the 1st Half of 2015

7 October 2015

DSM Group summed up the second quarter of 2015 and analyzed the volume of Russian pharmaceutical market for the first half year.

The second quarter of 2015 the growth of Russian pharmaceutical market has slowed compared to the beginning of the year. According to preliminary data, the increase will amount to 13.9% in ruble terms relative to the 2nd quarter of 2014.

In general, half a year market growth will be below 18%. In real terms, there is stagnation. Changes in volume of the market in packages - in the range of +/- 1%, due to a marked fall in the market in packaging in 2014 (-4.5%).

Segment showing high growth in 2015 remains a segment of the pharmacy drug sales: +19.8% for the 2nd quarter and +22.5% for six months. One of the drivers of market growth is inflation. It should be noted that in the second quarter of 2015 there was a decline in prices of 2.1% compared to March of 2015. In general, for 6 months of 2015 prices have increased by 6.5%. And taking into account inflation 2014, medicines are on average 20% more expensive for consumer than in the 2nd quarter of 2014. In this regard, there is a further reduction of cheap products in the sales structure. So, by the end of June, the share of drugs priced below 50 rubles amounted to 6.8%.

Parapharma pharmacy - the most vulnerable part of the range of pharmacy during crisis period, 2015 was no exception. Despite the rise in prices in monetary terms, the segment shows a modest rate - about 12% in the first half of the year. In 2015, the most affected parapharma pharmacy segment is a cosmetics, whose sales are falling.

Packaging the largest increase in ASD segment (4.4%). The growth in FPP is only 1.2%. But in hospital audit segment a decrease (-8,7%) is observed.

Table 1. Russian pharmaceutical market volume by segment for the 2nd quarter of 2015

Segment

Volume, mln. RUB

Growth

Volume, mln. package

Growth

Q2 2014

Q2 2015

Q2 2014

Q2 2015

FPP commercial sales

151 293

181 201

19,8%

973

985

1,2%

Parapharmaceuticals

44 473

48 736

9,6%

 

 

 

APS

13 751

15 568

13,2%

14

14

4,4%

Hospital audit

46 178

45 674

-1,1%

248

227

-8,7%

TOTAL

255 696

291 178

13,9%

1 235

1 226

-0,7%

 

State segment is growing in 2015. Note that for the 1st half supply of medicines under the program of preferential provision of medicines increased substantially. For the first 6 months in pharmacies was taken drugs in the amount of 64 billion rubles, which is 22% higher than in 2014. Also in this segment is observed positive dynamics in packages.

The segment of hospital purchases shows the indicators at the level of 2014 in monetary terms. But according to the results 1st half-year in real terms was

The result of two quarters of 2015 was the growth of the pharmaceutical market of Russia as a whole is 17.3%% in roubles and 0.2% in packages.

Table 2. Russian pharmaceutical market volume by segment for the 1st half of 2015

Segment

Volume, mln. RUB

Growth

Volume, mln. package

Growth

H1 2014

H1 2015

H1 2014

H1 2015

FPP commercial sales

314 911

385 882

22,5%

2 063

2 103

1,9%

Parapharmaceuticals

87 107

97 385

11,8%

 

 

 

APS

52 642

64 224

22,0%

40

40

1,5%

Hospital audit

91 676

93 510

2,0%

482

448

-7,0%

ИТОГО

546 337

641 001

17,3%

2 585

2 591

0,2%

 


Source: DSM Group   back to headlines